Global Patent Index - EP 0409845 A4

EP 0409845 A4 19910703 - METHOD FOR PROTECTION FROM CHEMOTHERAPEUTIC SIDE EFFECTS

Title (en)

METHOD FOR PROTECTION FROM CHEMOTHERAPEUTIC SIDE EFFECTS

Publication

EP 0409845 A4 19910703 (EN)

Application

EP 89902904 A 19890221

Priority

US 15910488 A 19880223

Abstract (en)

[origin: WO8907942A1] S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate and pharmaceutically acceptable derivatives thereof are useful in protecting a patient undergoing chemotherapy from cardiotoxic and bone marrow toxic side effects associated with administration of chemotherapeutic agents.

IPC 1-7

A61K 31/66

IPC 8 full level

A61K 31/66 (2006.01); A61K 31/70 (2006.01); A61P 35/00 (2006.01); A61P 39/02 (2006.01); A61P 43/00 (2006.01)

CPC (source: EP)

A61K 31/66 (2013.01); A61P 35/00 (2017.12); A61P 39/02 (2017.12); A61P 43/00 (2017.12)

Citation (search report)

  • Proceedings of the 9th Annual Conference of the IEEE Engineering in Medicine and Biology Society, Boston, 13th-16th November 1987, pages 1443-1445, New York, US; M.-A. RIX-MONTEL: "Radioprotective effects of thiophosphates", whole article.
  • American Association for Cancer Research Proceedings, Vol. 22, March 1981, page 271, Abstract No. 1075, Washington, DC, US; T.L. PHILLIPS et al.: "Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs, intestinal crypt cells, EMT6 tumor", whole article.
  • J. Pharmacobio.-Dynamics, Vol. 3, No. 7, July 1980, page s-21; M. ONODA et al.: "Effect of various kinds of drugs in vitro on the proliferation of leukopoietic stem cells (CFU-C)", whole article.
  • Drugs of the Future, Vol. 14, No. 11, November 1989, pages 1105-1107; whole article.
  • See references of WO 8907942A1

Designated contracting state (EPC)

AT BE CH DE FR GB IT LI LU NL SE

DOCDB simple family (publication)

WO 8907942 A1 19890908; AU 3194089 A 19890922; AU 636107 B2 19930422; CA 1336506 C 19950801; EP 0409845 A1 19910130; EP 0409845 A4 19910703; JP H03503888 A 19910829

DOCDB simple family (application)

US 8900624 W 19890221; AU 3194089 A 19890221; CA 591907 A 19890223; EP 89902904 A 19890221; JP 50269689 A 19890221